EBITDA Growth
38.79%
Quarterly · Period ending:
LUNG EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported38.79%period ending
Latest reported38.79%period ending
LUNG Quarterly EBITDA YoY % (-18.56% → 38.79%)
Year-over-year change
High-resolution chart · PNG
LUNG ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 38.7898% | |
| 16.9209% | |
| 23.0231% | |
| -0.7331% | |
| 0.3799% | |
| -20.8779% | |
| 2.8102% | |
| 6.2662% | |
| 5.6217% | |
| 16.7776% | |
| 7.102% | |
| -0.2222% | |
| -5.5782% | |
| 3.0734% | |
| -8.2322% | |
| -38.8626% | |
| -11.7398% | |
| -31.9583% | |
| -37.0036% | |
| -276.0247% | |
| -15.7399% | |
| -89.9852% | |
| -126.3636% | |
| 29.9377% | |
| -121.1645% | |
| -18.5642% |